Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients

Current Problems in Dermatology (Switzerland)

Volumn 49, Issue , 2016, Pages 8-26

  Van Smeden, Jeroen ^a   Bouwstra, Joke A ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; CERAMIDASE; ELONGASE; ENZYME; FILAGGRIN; GAMMA INTERFERON; GLUCOSYLCEREBROSIDASE; HYDROXY FATTY ACID; INTERLEUKIN 4; MESSENGER RNA; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SERINE PALMITOYL TRANSFERASE; SKIN LIPID; SPHINGOMYELIN; SPHINGOMYELIN DEACYLASE; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG; CERAMIDE; CHOLESTEROL; FATTY ACID; INTERMEDIATE FILAMENT PROTEIN; LIPID;

ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; GENE MUTATION; HUMAN; LIPID BILAYER; LIPID COMPOSITION; LIPID METABOLISM; LIPOGENESIS; PRIORITY JOURNAL; STRATUM CORNEUM; BIOSYNTHESIS; CHEMISTRY; EPIDERMIS; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENETICS; METABOLISM; MUTATION; NORMAL HUMAN; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; THERMOREGULATION;

CERAMIDES; CHOLESTEROL; DERMATITIS, ATOPIC; EPIDERMIS; FATTY ACIDS; HEALTHY VOLUNTEERS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; LIPID METABOLISM; LIPIDS; MUTATION; PERMEABILITY; SKIN PHYSIOLOGICAL PHENOMENA; WATER LOSS, INSENSIBLE;

EID: 84957623540     PISSN: 14215721     EISSN: 16622944     Source Type: Book Series    
DOI: 10.1159/000441540     Document Type: Article

References (96)

1. McLean WH, Hull PR: Breach delivery: increased solute uptake points to a defective skin barrier in atopic dermatitis. J Invest Dermatol 2007; 127: 8-10.
2. Michaels AS, Chandrasekaran SK, Shaw JE: Drug permeation through human skin-theory and in vitro experimental measurement. AIChE J 1975; 21: 985-996.
3. Simon M, Haftek M, Sebbag M, Montezin M, Girbal-Neuhauser E, Schmitt D, Serre G: Evidence that filaggrin is a component of cornified cell envelopes in human plantar epidermis. Biochem J 1996; 137: 173-177.
4. Armengot-Carbo M, Hernandez-Martin A, Torrelo A: The role of filaggrin in the skin barrier and disease development. Actas Dermosifiliogr 2015; 106: 86-95.
5. Irvine AD, McLean WH: Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 2006; 126: 1200-1202.
6. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, Di-Giovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-446.
7. Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, Liao H, Evans AT, Goudie DR, Lewis-Jones S, Arseculeratne G, Munro CS, Sergeant A, O'Regan G, Bale SJ, Compton JG, Digiovanna JJ, Presland RB, Fleckman P, McLean WH: Loss-of-function mutations in the gene encoDing filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38: 337-342.
8. Irvine AD, McLean WHI, Leung DYM: Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315-1327.
9. WeiDinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, Klopp N, Wagenpfeil S, Zhao Y, Liao H, Lee SP, Palmer CN, Jenneck C, Maintz L, Hagemann T, Behrendt H, Ring J, Nothen MM, McLean WH, Novak N: Loss-offunction variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006; 118: 214-219.
10. Paternoster L, Standl M, Chen CM, Ramasamy A, Bonnelykke K, Duijts L, Ferreira MA, Alves AC, Thyssen JP, Albrecht E, Baurecht H, Feenstra B, Sleiman PM, Hysi P, Warrington NM, Curjuric I, Myhre R, Curtin JA, Groen-Blokhuis MM, Kerkhof M, Saaf A, Franke A, Ellinghaus D, Folster-Holst R, Dermitzakis E, Montgomery SB, Prokisch H, Heim K, Hartikainen AL, Pouta A, Pekkanen J, Blakemore AI, Buxton JL, Kaakinen M, Duffy DL, Madden PA, Heath AC, Montgomery GW, Thompson PJ, Matheson MC, Le Souef P, Australian Asthma Genetics Consortium (AAGC), St Pourcain B, Smith GD, Henderson J, Kemp JP, Timpson NJ, Deloukas P, Ring SM, Wichmann HE, Muller-Nurasyid M, Novak N, Klopp N, Rodriguez E, McArdle W, Linneberg A, Menne T, Nohr EA, Hofman A, Uitterlinden AG, van Duijn CM, Rivadeneira F, de Jongste JC, van der Valk RJ, Wjst M, Jogi R, Geller F, Boyd HA, Murray JC, Kim C, Mentch F, March M, Mangino M, Spector TD, Bataille V, Pennell CE, Holt PG, Sly P, Tiesler CM, Thiering E, Illig T, Imboden M, Nystad W, Simpson A, Hottenga JJ, Postma D, Koppelman GH, Smit HA, Soderhall C, Chawes B, Kreiner-Moller E, Bisgaard H, Melen E, Boomsma DI, Custovic A, Jacobsson B, Probst-Hensch NM, Palmer LJ, Glass D, Hakonarson H, Melbye M, Jarvis DL, Jaddoe VW, Gieger C, Genetics of Overweight Young Adults (GOYA) Consortium, Strachan DP, Martin NG, Jarvelin MR, Heinrich J, Evans DM, WeiDinger S, EArly Genetics & Lifecourse Epidemiology (EAGLE) Consortium: Meta-analysis of genome-wide association studies identified three new risk loci for atopic dermatitis. Nat Genet 2012; 44: 187-192.
11. Brown SJ, Kroboth K, Sandilands A, Campbell LE, Pohler E, Kezic S, Cordell HJ, McLean WH, Irvine AD: Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect. J Invest Dermatol 2012; 132: 98-104.
12. Jakasa I, Koster ES, Calkoen F, McLean WH, Campbell LE, Bos JD, Verberk MM, Kezic S: Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin lossof-function mutations. J Invest Dermatol 2011; 131: 540-542.
13. O'Regan GM, Kemperman PM, Sandilands A, Chen H, Campbell LE, Kroboth K, Watson R, Rowland M, Puppels GJ, McLean WH, Caspers PJ, Irvine AD: Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. J Allergy Clin Immunol 2010; 126: 574.e1-580.e1.
14. Flohr C, England K, Radulovic S, McLean WH, Campbel LE, Barker J, Perkin M, Lack G: Filaggrin loss-offunction mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. Br J Dermatol 2010; 163: 1333-1336.
15. Winge MC, Hoppe T, Berne B, Vahlquist A, Nordenskjold M, Bradley M, Torma H: Filaggrin genotype determines functional and molecular alterations in skin of patients with atopic dermatitis and ichthyosis vulgaris. PLoS One 2011; 6:e28254.
16. Thyssen JP, Kezic S: Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 2014; 134: 792-799.
17. Perusquia-Ortiz AM, Oji V, Sauerland MC, Tarinski T, Zaraeva I, Seller N, Metze D, Aufenvenne K, Hausser I, Traupe H: Complete filaggrin deficiency in ichthyosis vulgaris is associated with only moderate changes in epidermal permeability barrier function profile. J Eur Acad Dermatol Venereol 2013; 27: 1552-1558.
18. Gruber R, Elias PM, Crumrine D, Lin TK, Brandner JM, Hachem JP, Presland RB, Fleckman P, Janecke AR, Sandilands A, McLean WH, Fritsch PO, Mildner M, Tschachler E, Schmuth M: Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol 2011; 178: 2252-2263.
19. Weerheim A, Ponec M: Determination of stratum corneum lipid profile by tape stripping in combination with high-performance thin-layer chromatography. Arch Dermatol Res 2001; 293: 191-199.
20. van Smeden J, Boiten WA, Hankemeier T, Rissmann R, Bouwstra JA, Vreeken RJ: Combined LC/MS-platform for analysis of all major stratum corneum lipids, and the profiling of skin substitutes. Biochim Biophys Acta 2014; 1841: 70-79.
21. Norlen L, Nicander I, Lundsjo A, Cronholm T, Forslind B: A new HPLC-based method for the quantitative analysis of inner stratum corneum lipids with special reference to the free fatty acid fraction. Arch Dermatol Res 1998; 290: 508-516.
22. Ponec M, Weerheim A, Lankhorst P, Wertz P: New acylceramide in native and reconstructed epidermis. J Invest Dermatol 2003; 120: 581-588.
23. Ansari MN, Nicolaides N, Fu HC: Fatty acid composition of the living layer and stratum corneum lipids of human sole skin epidermis. Lipids 1970; 5: 838-845.
24. Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R: Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1993; 1182: 147-151.
25. Masukawa Y, Narita H, Shimizu E, Kondo N, Sugai Y, Oba T, Homma R, Ishikawa J, Takagi Y, Kitahara T, Takema Y, Kita K: Characterization of overall ceramide species in human stratum corneum. J Lipid Res 2008; 49: 1466-1476.
26. van Smeden J, Hoppel L, van der Heij den R, Hankemeier T, Vreeken RJ, Bouwstra JA: LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery. J Lipid Res 2011; 52: 1211-1221.
27. t'Kindt R, Jorge L, Dumont E, Couturon P, David F, Sandra P, Sandra K: Profiling and characterizing skin ceramides using reversed-phase liquid chromatographyquadrupole time-of-flight mass spectrometry. Anal Chem 2012; 84: 403-411.
28. Rabionet M, Bayerle A, Marsching C, Jennemann R, Grone HJ, Yildiz Y, Wachten D, Shaw W, Shayman JA, Sandhoff R: 1-O-acylceramides are natural components of human and mouse epidermis. J Lipid Res 2013; 54: 3312-3321.
29. Gray GM, White RJ: Glycosphingolipids and ceramides in human and pig epidermis. J Invest Dermatol 1978; 70: 336-341.
30. Wertz PW, Miethke MC, Long SA, Strauss JS, Downing DT: The composition of the ceramides from human stratum corneum and from comedones. J Invest Dermatol 1985; 84: 410-412.
31. Robson KJ, Stewart ME, Michelsen S, Lazo ND, Downing DT: 6-Hydroxy-4-sphingenine in human epidermal ceramides. J Lipid Res 1994; 35: 2060-2068.
32. Stewart ME, Downing DT: A new 6-hydroxy-4-sphingenine-containing ceramide in human skin. J Lipid Res 1999; 40: 1434-1439.
33. Masukawa Y, Narita H, Sato H, Naoe A, Kondo N, Sugai Y, Oba T, Homma R, Ishikawa J, Takagi Y, Kitahara T: Comprehensive quantification of ceramide species in human stratum corneum. J Lipid Res 2009; 50: 1708-1719.
34. Shin JH, Shon JC, Lee K, Kim S, Park CS, Choi EH, Lee CH, Lee HS, Liu KH: A lipidomic platform establishment for structural identification of skin ceramides with non-hydroxyacyl chains. Anal Bioanal Chem 2014; 406: 1917-1932.
35. Joo KM, Hwang JH, Bae S, Nahm DH, Park HS, Ye YM, Lim KM: Relationship of ceramide-, and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins. J Dermatol Sci 2015; 77: 71-74.
36. van Smeden J, Janssens M, Kaye EC, Caspers PJ, Lavrijsen AP, Vreeken RJ, Bouwstra JA: The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients. Exp Dermatol 2014; 23: 45-52.
37. Madison KC, Swartzendruber DC, Wertz PW, Downing DT: Presence of intact intercellular lipid lamellae in the upper layers of the stratum corneum. J Invest Dermatol 1987; 88: 714-718.
38. Bouwstra JA, Gooris GS, van der Spek JA, Bras W: Structural investigations of human stratum corneum by small-angle X-ray scattering. J Invest Dermatol 1991; 97: 1005-1012.
39. Garson JC, Doucet J, Leveque JL, Tsoucaris G: Oriented structure in human stratum corneum revealed by X-ray diffraction. J Invest Dermatol 1991; 96: 43-49.
40. Schreiner V, Gooris GS, Pfeiffer S, Lanzendorfer G, Wenck H, Diembeck W, Proksch E, Bouwstra J: Barrier characteristics of different human skin types investigated with X-ray diffraction, lipid analysis, and electron microscopy imaging. J Invest Dermatol 2000; 114: 654-660.
41. Thakoersing VS, Danso MO, Mulder A, Gooris G, El Ghalbzouri A, Bouwstra JA: Nature versus nurture: does human skin maintain its stratum corneum lipid properties in vitro? Exp Dermatol 2012; 21: 865-870.
42. Thakoersing VS, van Smeden J, Mulder AA, Vreeken RJ, El Ghalbzouri A, Bouwstra JA: Increased presence of monounsaturated fatty acids in the stratum corneum of human skin equivalents. J Invest Dermatol 2013; 133: 59-67.
43. Gay CL, Guy RH, Golden GM, Mak VH, Francoeur ML: Characterization of lowtemperature (i.e., <65 degrees C) lipid transitions in human stratum corneum. J Invest Dermatol 1994; 103: 233-239.
44. Mak VH, Potts RO, Guy RH: Percutaneous penetration enhancement in vivo measured by attenuated total reflectance infrared spectroscopy. Pharm Res 1990; 7: 835-841.
45. Bouwstra JA, Gooris GS, Salomonsdevries MA, Vanderspek JA, Bras W: Structure of human stratum-corneum as a function of temperature and hydration-a wide-angle X-ray-diffraction study. Int J Pharm 1992; 84: 205-216.
46. Pilgram GS, Engelsma-van Pelt AM, Bouwstra JA, Koerten HK: Electron diffraction provides new information on human stratum corneum lipid organization studied in relation to depth and temperature. J Invest Dermatol 1999; 113: 403-409.
47. Doucet J, Potter A, Baltenneck C, Domanov YA: Micron-scale assessment of molecular lipid organization in human stratum corneum using microprobe X-ray diffraction. J Lipid Res 2014; 55: 2380-2388.
48. Mojumdar EH, Helder RW, Gooris GS, Bouwstra JA: Monounsaturated fatty acids reduce the barrier of stratum corneum lipid membranes by enhancing the formation of a hexagonal lateral packing. Langmuir 2014; 30: 6534-6543.
49. Ishikawa J, Narita H, Kondo N, Hotta M, Takagi Y, Masukawa Y, Kitahara T, Takema Y, Koyano S, Yamazaki S, Hatamochi A: Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol 2010; 130: 2511-2514.
50. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96: 523-526.
51. Yamamoto A, Serizawa S, Ito M, Sato Y: Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res 1991; 283: 219-223.
52. Farwanah H, Raith K, Neubert RH, Wohlrab J: Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin. Arch Dermatol Res 2005; 296: 514-521.
53. Angelova-Fischer I, Mannheimer AC, Hinder A, Ruether A, Franke A, Neubert RH, Fischer TW, Zillikens D: Distinct barrier integrity phenotypes in filaggrinrelated atopic eczema following sequential tape stripping and lipid profiling. Exp Dermatol 2011; 20: 351-356.
54. Di Nardo A, Wertz P, Giannetti A, Seidenari S: Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998; 78: 27-30.
55. Bleck O, Abeck D, Ring J, Hoppe U, Vietzke JP, Wolber R, Brandt O, Schreiner V: Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of nonlesional skin of atopic eczema. J Invest Dermatol 1999; 113: 894-900.
56. Jungersted JM, Scheer H, Mempel M, Baurecht H, Cifuentes L, Hogh JK, Hellgren LI, Jemec GB, Agner T, WeiDinger S: Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy 2010; 65: 911-918.
57. Janssens M, van Smeden J, Gooris GS, Bras W, Portale G, Caspers PJ, Vreeken RJ, Hankemeier T, Kezic S, Wolterbeek R, Lavrijsen AP, Bouwstra JA: Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res 2012; 53: 2755-2766.
58. Tawada C, Kanoh H, Nakamura M, Mizutani Y, Fujisawa T, Banno Y, Seishima M: Interferon-gamma decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis. J Invest Dermatol 2014; 134: 712-718.
59. Macheleidt O, Kaiser HW, Sandhoff K: Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002; 119: 166-173.
60. Fartasch M, Bassukas ID, Diepgen TL: Disturbed extruDing mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 1992; 127: 221-227.
61. Elias PM, Schmuth M: Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 2009; 9: 437-446.
62. Janssens M, van Smeden J, Puppels GJ, Lavrijsen AP, Caspers PJ, Bouwstra JA: Lipid to protein ratio plays an important role in the skin barrier function in patients with atopic eczema. Br J Dermatol 2014; 170: 1248-1255.
63. Elias PM, Sun R, Eder AR, Wakefield JS, Man M-Q: Treating atopic dermatitis at the source: corrective barrier repair therapy based upon new pathogenic insights. Exp Rev Dermatol 2013; 8: 27-36.
64. Pilgram GS, Vissers DC, van der Meulen H, Pavel S, Lavrijsen SP, Bouwstra JA, Koerten HK: Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 2001; 117: 710-717.
65. Mojumdar EH, Kariman Z, van Kerckhove L, Gooris GS, Bouwstra JA: The role of ceramide chain length distribution on the barrier properties of the skin lipid membranes. Biochim Biophys Acta 2014; 1838: 2473-2483.
66. de Jager M, Groenink W, Bielsa i Guivernau R, Andersson E, Angelova N, Ponec M, Bouwstra J: A novel in vitro percutaneous penetration model: evaluation of barrier properties with p-aminobenzoic acid and two of its derivatives. Pharm Res 2006; 23: 951-960.
67. Park YH, Jang WH, Seo JA, Park M, Lee TR, Kim DK, Lim KM: Decrease of ceramides with very long-chain fatty acids and downregulation of elongases in a murine atopic dermatitis model. J Invest Dermatol 2012; 132: 476-479.
68. Nakajima K, Terao M, Takaishi M, Kataoka S, Goto-Inoue N, Setou M, Horie K, Sakamoto F, Ito M, Azukizawa H, Kitaba S, Murota H, Itami S, Katayama I, Takeda J, Sano S: Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model. J Invest Dermatol 2013; 133: 2555-2565.
69. Jennemann R, Rabionet M, Gorgas K, Epstein S, Dalpke A, Rothermel U, Bayerle A, van der Hoeven F, Imgrund S, Kirsch J, Nickel W, Willecke K, Riezman H, Grone HJ, Sandhoff R: Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum Mol Genet 2012; 21: 586-608.
70. Eckl KM, Tidhar R, Thiele H, Oji V, Hausser I, Brodesser S, Preil ML, Onal-Akan A, Stock F, Muller D, Becker K, Casper R, Nurnberg G, Altmuller J, Nurnberg P, Traupe H, Futerman AH, Hennies HC: Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length. J Invest Dermat 2013; 133: 2202-2211.
71. van Smeden J, Janssens M, Gooris GS, Bouwstra JA: The important role of stratum corneum lipids for the cutaneous barrier function. Biochim Biophys Acta 2014; 1841: 295-313.
72. Hachem JP, Man MQ, Crumrine D, Uchida Y, Brown BE, Rogiers V, Roseeuw D, Feingold KR, Elias PM: Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 2005; 125: 510-520.
73. Holleran WM, Takagi Y, Imokawa G, Jackson S, Lee JM, Elias PM: â-Glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation. J Lipid Res 1992; 33: 1201-1209.
74. Mauro T, Holleran WM, Grayson S, Gao WN, Man MQ, Kriehuber E, Behne M, Feingold KR, Elias PM: Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res 1998; 290: 215-222.
75. Jensen JM, Folster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C, Schutze S, Proksch E: Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122: 1423-1431.
76. Oizumi A, Nakayama H, Okino N, Iwahara C, Kina K, Matsumoto R, Ogawa H, Takamori K, Ito M, Suga Y, Iwabuchi K: Pseudomonas-derived ceramidase induces production of inflammatory mediators from human keratinocytes via sphingosine-1-phosphate. PLoS One 2014; 9:e89402.
77. Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G: The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J 2000; 350: 747-756.
78. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G: High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leaDing to barrier disruption in atopic dermatitis. J Invest Dermatol 2000; 115: 406-413.
79. van Drongelen V, Alloul-Ramdhani M, Danso MO, Mieremet A, Mulder A, van Smeden J, Bouwstra JA, El Ghalbzouri A: Knock-down of filaggrin does not affect lipid organization and composition in stratum corneum of reconstructed human skin equivalents. Exp Dermatol 2013; 22: 807-812.
80. Mildner M, Jin J, Eckhart L, Kezic S, Gruber F, Barresi C, Stremnitzer C, Buchberger M, Mlitz V, Ballaun C, Sterniczky B, FoDinger D, Tschachler E: Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J Invest Dermatol 2010; 130: 2286-2294.
81. Vavrova K, Henkes D, Struver K, Sochorova M, Skolova B, Witting MY, Friess W, Schreml S, Meier RJ, Schafer-Korting M, Fluhr JW, Kuchler S: Filaggrin deficiency leads to impaired lipid profile and altered acidification pathways in a 3D skin construct. J Invest Dermatol 2014; 134: 746-753.
82. Cole C, Kroboth K, Schurch NJ, Sandilands A, Sherstnev A, O'Regan GM, Watson RM, McLean WH, Barton GJ, Irvine AD, Brown SJ: Filaggrinstratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis. J Allergy Clin Immunol 2014; 134: 82-91.
83. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, Duff GW, Ward SJ, Tazi-Ahnini R: New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006; 118: 3-21; quiz 22-23.
84. Kezic S, Kemperman PM, Koster ES, de Jongh CM, Thio HB, Campbell LE, Irvine AD, McLean WH, Puppels GJ, Caspers PJ: Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 2008; 128: 2117-2119.
85. Kezic S, O'Regan GM, Lutter R, Jakasa I, Koster ES, Saunders S, Caspers P, Kemperman PM, Puppels GJ, Sandilands A, Chen H, Campbell LE, Kroboth K, Watson R, Fallon PG, McLean WH, Irvine AD: Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol 2012; 129: 1031.e1-1039.e1.
86. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM: pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003; 121: 345-353.
87. Hanson KM, Behne MJ, Barry NP, Mauro TM, Gratton E, Clegg RM: Two-photon fluorescence lifetime imaging of the skin stratum corneum pH gradient. Biophys J 2002; 83: 1682-1690.
88. Elias PM, Wakefield JS: Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 2014; 134: 781.e1-791.e1.
89. Elias PM, Steinhoff M: 'Outside-to-inside' (and now back to 'outside') pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008; 128: 1067-1070.
90. Hatano Y, Terashi H, Arakawa S, Katagiri K: Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factoralpha and interferon-gamma in human epidermis. J Invest Dermatol 2005; 124: 786-792.
91. Danso MO, van Drongelen V, Mulder A, van Esch J, Scott H, van Smeden J, El Ghalbzouri A, Bouwstra JA: TNF-alpha and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. J Invest Dermatol 2014; 134: 1941-1950.
92. Lee HJ, Lee SH: Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis. Allergy Asthma Immunol Res 2014; 6: 276-287.
93. Elias PM: Barrier-repair therapy for atopic dermatitis: corrective lipid biochemical therapy. Expert Rev Dermatol 2008; 3: 441-452.
94. van Smeden J, Janssens M, Boiten WA, van Drongelen V, Furio L, Vreeken RJ, Hovnanian A, Bouwstra JA: Intercellular skin barrier lipid composition and organization in Netherton syndrome patients. J Invest Dermatol 2014; 134: 1238-1245.
95. Hovnanian A: Netherton syndrome: skin inflammation and allergy by loss of protease inhibition. Cell Tissue Res 2013; 351: 289-300.
96. Bonnart C, Deraison C, Lacroix M, Uchida Y, Besson C, Robin A, Briot A, Gonthier M, Lamant L, Dubus P, Monsarrat B, Hovnanian A: Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 2010; 120: 871-882.